Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary

por Ball, Susan G, Desaiah, Durisala, Zhang, Qi, Thase, Michael E, Perahia, David G S
Publicado 2013

Duloxetine in the treatment of major depressive disorder: an open-label study

por Hudson, James I, Perahia, David G, Gilaberte, Inmaculada, Wang, Fujun, Watkin, John G, Detke, Michael J
Publicado 2007

Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database

por Lin, Nancy D., Norman, Heather, Regev, Arie, Perahia, David G., Li, Hu, Chang, Curtis Liming, Dore, David D.
Publicado 2015

The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse e...

por Perahia, David G, Bangs, Mark E, Zhang, Qi, Cheng, Yingkai, Ahl, Jonna, Frakes, Elijah P, Adams, Michael J, Martinez, James M
Publicado 2013

Safety, Tolerability, and Pharmacokinetics of Zagotenemab in Participants with Symptomatic Alzheimer’s Disease: A Phase I Clinical Trial

por Willis, Brian A., Lo, Albert C., Dage, Jeffrey L., Shcherbinin, Sergey, Chinchen, Louise, Andersen, Scott W., LaBell, Elizabeth S., Perahia, David G.S., Hauck, Paula M., Lowe, Stephen L.
Publicado 2023